18FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns - Archive ouverte HAL
Article Dans Une Revue European Journal of Nuclear Medicine and Molecular Imaging Année : 2020

18FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns

Résumé

This prospective study aimed (1) to assess the non-small cell lung cancer (NSCLC) evolutive patterns to immunotherapy using FDG-PET and (2) to describe their association with clinical outcome.
Fichier non déposé

Dates et versions

hal-02563277 , version 1 (05-05-2020)

Identifiants

Citer

Olivier Humbert, Nour Cadour, R. Schiappa, M. Poudenx, D. Chardin, et al.. 18FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns. European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 (5), pp.1158-1167. ⟨10.1007/s00259-019-04573-4⟩. ⟨hal-02563277⟩
102 Consultations
0 Téléchargements

Altmetric

Partager

More